We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+11.21%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$1.61B
AUM Growth
+$95.7M
Cap. Flow
-$7.31M
Cap. Flow %
-0.45%
Top 10 Hldgs %
28.48%
Holding
136
New
14
Increased
29
Reduced
19
Closed
10

Top Buys

Rank Stock Value
1
TTD icon
Trade Desk
TTD
+$22.4M
2
AVXS
AveXis, Inc. Common Stock
AVXS
+$19.4M
3
HUBS icon
HubSpot
HUBS
+$14M
4
AIMT
Aimmune Therapeutics
AIMT
+$13.7M
5
APTV icon
Aptiv
APTV
+$13.2M

Top Sells

Rank Stock Value
1
ROL icon
Rollins
ROL
+$21.9M
2
AYI icon
Acuity Brands
AYI
+$17.5M
3
LRCX icon
Lam Research
LRCX
+$14.7M
4
OPLN
Openlane
OPLN
+$13.9M
5
XPO icon
XPO
XPO
+$13.3M

Sector Composition

Rank Sector Weight
1 Healthcare 35.06%
2 Technology 14.25%
3 Consumer Discretionary 14.02%
4 Industrials 8.96%
5 Utilities 4.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCRX icon
101
BioCryst Pharmaceuticals
BCRX
$2.35B
$1.61M 0.1%
+290,000
New +$1.77M
BEP icon
102
Brookfield Renewable
BEP
$9.9B
$1.55M 0.1%
91,010
+7,506
+9% +$126K
PTGX icon
103
Protagonist Therapeutics
PTGX
$8.92B
$1.41M 0.09%
+125,000
New +$1.34M
HMC icon
104
Honda
HMC
$39.9B
$1.37M 0.09%
50,000
+20,000
+67% +$566K
KALV
105
DELISTED
KalVista Pharmaceuticals
KALV
$1.37M 0.09%
189,900
+91,800
+94% +$675K
TSM icon
106
TSMC
TSM
$2.09T
$1.36M 0.08%
39,000
-4,000
-9% -$138K
BHVN
107
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$1.33M 0.08%
+53,240
New +$1.23M
HTGC icon
108
Hercules Capital
HTGC
$2.98B
$1.32M 0.08%
100,000
– –
EPIX
109
DELISTED
ESSA Pharma
EPIX
$1.31M 0.08%
135,971
– –
FHB icon
110
First Hawaiian
FHB
$3.4B
$1.29M 0.08%
42,000
+18,000
+75% +$526K
CWEN icon
111
Clearway Energy Class C
CWEN
$4.94B
$1.21M 0.08%
69,000
-1,000
-1% -$17.5K
DRNA
112
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$1.2M 0.07%
377,000
– –
BDN
113
Brandywine Realty Trust
BDN
$525M
$1.18M 0.07%
67,500
+7,000
+12% +$120K
BG icon
114
Bunge Global
BG
$20.4B
$1.01M 0.06%
13,500
+5,000
+59% +$380K
APU
115
DELISTED
AmeriGas Partners, L.P.
APU
$903K 0.06%
+20,000
New +$898K
GLBL
116
DELISTED
TerraForm Global, Inc. Class A Common Stock
GLBL
$808K 0.05%
160,000
+35,000
+28% +$169K
WBK
117
DELISTED
Westpac Banking Corporation
WBK
$761K 0.05%
32,500
+12,000
+59% +$291K
ETN icon
118
Eaton
ETN
$150B
$700K 0.04%
9,000
+2,500
+38% +$191K
ERIC icon
119
Ericsson
ERIC
$32.1B
$645K 0.04%
90,000
+31,000
+53% +$210K
TERP
120
DELISTED
TerraForm Power, Inc
TERP
$516K 0.03%
43,000
+32,000
+291% +$392K
LXP icon
121
LXP Industrial Trust
LXP
$3.52B
$496K 0.03%
10,000
+2,300
+30% +$115K
LPT
122
DELISTED
Liberty Property Trust
LPT
$489K 0.03%
12,000
– –
VTR icon
123
Ventas
VTR
$44.7B
$486K 0.03%
7,000
– –
WELL icon
124
Welltower
WELL
$170B
$412K 0.03%
5,500
– –
AYI icon
125
Acuity Brands
AYI
$10.1B
$407K 0.03%
2,000
-99,000
-98% -$17.5M
2 3 4
5
6

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q2 2017 Portfolio in Review

As of Q2 2017, Eventide Asset Management held 136 positions worth $1.61B, up 6.3% from $1.51B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Eventide Asset Management's Q2 2017 filing shows 14 new, 29 increased, 19 reduced and 10 closed positions. Its largest new stake was Trade Desk: 4,900,000 shares worth $24.6M. The largest sale was Rollins, an estimated $21.9M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Eventide Asset Management's largest Q2 2017 buy was Trade Desk: 4,900,000 shares worth $24.6M.
  • Eventide Asset Management added most to AveXis, Inc. Common Stock in Q2 2017, an estimated $19.4M increase.
  • Eventide Asset Management's biggest Q2 2017 reduction was Acuity Brands, cutting an estimated $17.5M.
  • Eventide Asset Management fully exited Rollins in Q2 2017, selling an estimated $21.9M.
  • Eventide Asset Management's ten largest holdings make up 28% of its $1.61B portfolio in Q2 2017.
  • Eventide Asset Management opened 14 new positions and closed 10 in Q2 2017.
  • Eventide Asset Management's portfolio value rose 6.3% quarter-over-quarter to $1.61B.

Based on Eventide Asset Management's 13F filing for Q2 2017, filed 14 Aug 2017.